Strong Chemical Segment Performance
Chemical segment EBITDA increased by 23% year-over-year, with specialty silicones sales markedly higher than the previous year and volumes remaining high.
Biosolutions Growth
Biosolutions segment sales rose by 29% year-over-year, supported by growth in biopharma. The new biopharma site in Halle provides a strong foundation for further growth.
Sustainability Initiatives
Wacker is committed to reaching net zero by 2045, with progress shown in reducing CO2 emissions and sourcing renewable energy for silicon metal production.
Continued Investment in Future Growth
Wacker confirmed full-year guidance, expecting EBITDA in the upper half of the EUR 600 million to EUR 800 million range, and continues to invest in future growth.